Nootropic peptides represent a fascinating intersection of neuroscience and peptide research. Selank Acetate is being investigated for its potential cognitive-enhancing and neuroprotective properties.
A synthetic heptapeptide analog of tuftsin with anxiolytic and nootropic properties. Studied for reducing anxiety without sedation and enhancing memory consolidation.
Also Known As
Selank, TP-7
What is Selank Acetate?
Selank Acetate is classified under the Nootropic category of peptides. A synthetic heptapeptide analog of tuftsin with anxiolytic and nootropic properties. Studied for reducing anxiety without sedation and enhancing memory consolidation.
Mechanism of Action: A synthetic analog of the immunomodulatory peptide tuftsin with a Pro-Gly-Pro C-terminal extension. It modulates IL-6, affects the balance of T-helper cell cytokines, influences BDNF expression, and interacts with the GABAergic system to produce anxiolytic effects.
Cognitive & Neuroprotection Research
Primary Research Areas: Anxiety disorders, cognitive enhancement, immune modulation, neuroprotection, depression.
Key Research Findings: Approved in Russia as an anxiolytic. Studies show reduced anxiety without sedation or addiction potential. It stabilizes enkephalin degradation and modulates the expression of brain BDNF. Immune studies show enhanced NK cell activity and normalized cytokine profiles.
Safety Profile & Considerations
Well-tolerated in Russian clinical use with minimal side effects. Not FDA or EMA approved. Typically administered intranasally. Long-term safety from Western regulatory trials is not established.
Related Research Topics
Understanding Selank Acetate requires familiarity with these related concepts in nootropic research. Each topic represents a broader field that intersects with current peptide research.
References & Further Reading
Uchakina ON, et al. Immunomodulatory activity of selank in patients with anxiety-asthenic disorders. Zh Nevrol Psikhiatr. 2008;108:71-75.
Stay Updated on Peptide Research
Get the latest science-backed articles on peptides delivered to your inbox.